Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

High levels of mutated p53 indicate metastatic phenotype

Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA
High levels of mutated p53 indicate metastatic phenotype ( Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA )
5 May 2014

History and ongoing work of AORTIC

Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya

Dr Lisa Stevens - National Cancer Institute, Bethesda, USA
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )
5 May 2014

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA
Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )
1 May 2014

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014

Impact of the liver environment upon the efficacy of induction therapy

Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France
Impact of the liver environment upon the efficacy of induction therapy ( Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France )
1 May 2014

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib

Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA
I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )
16 Apr 2014

New tools can help tackle flawed decision-making process for HER2- patients

Dr Matti Aapro - Multidisciplinary Oncology Institute, Clinique De Genolier, Switzerland
New tools can help tackle flawed decision-making process for HER2- patients ( Dr Matti Aapro - Multidisciplinary Oncology Institute, Clinique De Genolier, Switzerland )
4 Apr 2014

Troubling differences in the success rates of breast cancer treatment across different countries

Dr Philippe Autier - International Prevention Research Unit, Lyons, France
Troubling differences in the success rates of breast cancer treatment across different countries ( Dr Philippe Autier - International Prevention Research Unit, Lyons, France )
4 Apr 2014

Obesity and diabetes should be taken into account when planning breast cancer treatment

Dr Caterina Fontanella - German Breast Group, Neu-Isenberg, Germany
Obesity and diabetes should be taken into account when planning breast cancer treatment ( Dr Caterina Fontanella - German Breast Group, Neu-Isenberg, Germany )
1 Apr 2014

Consensus on the treatment of breast cancer and early intervention using endocrine therapy

Prof Nadia Harbeck - University of Munich, Munich, Germany
Consensus on the treatment of breast cancer and early intervention using endocrine therapy ( Prof Nadia Harbeck - University of Munich, Munich, Germany )
1 Apr 2014

Breast cancer screening in the UK: does it work?

Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK
Breast cancer screening in the UK: does it work? ( Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK )
1 Apr 2014